GlassScriptPhysician profile
Hamayun S Mian
NPI 1124020870
$6,226.33
in general payments reported to CMS, 2019-2025
41 companies · $605 in 2025
The $605 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $352 · 2021: $1,005 · 2022: $2,062 · 2023: $1,225 · 2024: $491 · 2025: $605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,150 · Education: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,149.97 |
| Education | $171.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $474.01 | 2021-2025 | Interstim |
| Astellas Pharma US INC | $454.29 | 2019-2024 | Myrbetriq, Xtandi |
| Teleflex LLC | $452.45 | 2022-2024 | Urolift |
| Abbvie INC. | $446.17 | 2019-2024 | |
| Dendreon Pharmaceuticals LLC | $408.18 | 2019-2023 | Provenge |
| Procept Biorobotics Corporation | $340.98 | 2022-2025 | |
| Janssen Biotech, INC. | $330.02 | 2019-2025 | Erleada |
| Sumitomo Pharma America, INC. | $305.73 | 2023-2024 | Orgovyx, Gemtesa |
| Pfizer INC. | $266.80 | 2019-2023 | |
| Olympus America INC. | $244.90 | 2020-2025 | Itind System, Soltive |
| Endo Pharmaceuticals INC. | $241.08 | 2019-2022 | |
| Allergan, INC. | $233.82 | 2019-2021 | |
| Edap Technomed INC | $195.82 | 2024-2025 | |
| Coloplast Corp | $168.82 | 2019-2024 | |
| Antares Pharma, INC. | $167.29 | 2021-2023 | Xyosted, Nocdurna, Tlando |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hamayun Mian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.